Keywords: biochem, pharma, expects, sales, royalties, grow, canada

BioChem Pharma expects sales and royalties to grow 20% in 2000

Article | 12 January 2000

Canada's BioChem Pharma, which discovered the antiviral therapylamivudine, licensed to Glaxo Wellcome, said it expects sales and royalties to increase 20% ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Epivir

Lamivudine

Nystatin

Go to drug listing